Research Grade Anti-SARS-CoV-2 RBD Antibody (BD55-5514)

Anti-SARS-CoV-2 RBD Antibody (BD55-5514) ( VK565456 ) is a research-grade recombinant antibody targeting Spike glycoprotein . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.

Спецификация

Species reactivity	SARS-CoV-2
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Form	Liquid
Storage	-20℃
Product category‌	Biosimilar
Target	Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2
Accession	P0DTC2
Host species	Human

Информация для заказа

Область использования: Антитела Puda	Производство:	Puda Scientific
	Метод:	Иммуногистохимия
	Объем:	1mg
	Кат. номер:	PD-A26-479-100
Цена (с НДС 22%):	по запросу	В корзину
Наименование: Research Grade Anti-SARS-CoV-2 RBD Antibody (BD55-5514). Примечание: